NOTICE TO THE MEDIA - The Government of Canada will hold a news conference on coronavirus disease (COVID-19), post-COVID condition, and other public health concerns (COVID-19)
OTTAWA, ON, Dec. 13, 2022 /CNW/ - The Honourable Jean-Yves Duclos, Minister of Health, along with Government of Canada officials, will provide an update on COVID-19, post-COVID condition, and other public health concerns.
After their remarks, they will be available to take questions from journalists.
Date December 14, 2022
Time 12:30 PM (EST)
Location
The news conference will be held in person at:
Room 200, Sir John A. Macdonald Building 144 Wellington Street, Ottawa
Participation in the question and answer portion of this event is in person or via Zoom, and is for accredited members of the Press Gallery only. Media who are not members of the Press Gallery may contact [email protected] for temporary access.
A teleconference line is also available for listening to the event:
Toll-free dial-in number (Canada/US): 1-866-805-7923
Local dial-in number: 613-960-7518
Participant passcode: 7030681
NOTE: To help ensure optimal simultaneous interpretation sound quality, journalists are encouraged to use a microphone (headphones/headset) or, when possible, a landline, and to avoid using speaker mode if queuing up for questions.
StateHouse Holdings Inc. ("StateHouse" or the "Company") , a California-focused, vertically integrated cannabis company, today announced further to its press release dated April 15, 2024, that the Ontario Securities Commission (the "OSC") has denied...
Grifols, S.A. ("Grifols") (MCE: GRF, MCE: GRF.P, NASDAQ: GRFS), a global healthcare company and leading manufacturer of plasma-derived medicines, today announces the filing of its Annual Report on Form 20-F for the fiscal year ended December 31,...
Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:
On Thursday, the FDA posted a safety communication to inform the public and healthcare providers that the agency has required and...
Unifor expects to achieve the wage increases and benefit improvements awarded to Ontario OCHU-CUPE and SEIU Healthcare members by Arbitrator William Kaplan in a recent decision....
Acadia Pharmaceuticals Inc. today announced that on April 10, 2024, the Compensation Committee of Acadia's Board of Directors (the "Committee") granted inducement awards consisting of non-qualified stock options to purchase 21,659 shares of common...
Calidi Biotherapeutics, Inc. , a clinical-stage biotechnology company developing a new generation of targeted immunotherapies, today announced the closing of its previously announced public offering of 15,197,500 shares of common stock (or pre-funded...
